Franca Ronchese
#163,930
Most Influential Person Now
Italian-New Zealand immunologist
Franca Ronchese's AcademicInfluence.com Rankings
Franca Ronchesebiology Degrees
Biology
#13807
World Rank
#17388
Historical Rank
Immunology
#1003
World Rank
#1027
Historical Rank
Download Badge
Biology
Franca Ronchese's Degrees
- Bachelors Biology University of Milan
- Masters Immunology University of Milan
- PhD Immunology University of Auckland
Similar Degrees You Can Earn
Why Is Franca Ronchese Influential?
(Suggest an Edit or Addition)According to Wikipedia, Franca Ronchese is an Italian-New Zealand immunologist. She currently leads the immune cell biology programme at the Malaghan Institute of Medical Research in Wellington, New Zealand and is a research professor at Victoria University of Wellington.
Franca Ronchese's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A2A adenosine receptor protects tumors from antitumor T cells (2006) (815)
- Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling (1993) (261)
- B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes (1993) (232)
- Differential T Cell Function and Fate in Lymph Node and Nonlymphoid Tissues (2002) (227)
- Langerhans cells cross-present antigen derived from skin (2006) (211)
- CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity1 (2000) (197)
- The role of B7 costimulation in T‐cell immunity (1999) (194)
- The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. (2004) (186)
- Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection (2020) (179)
- Dendritic Cells Loaded with Stressed Tumor Cells Elicit Long-Lasting Protective Tumor Immunity in Mice Depleted of CD4+CD25+ Regulatory T Cells1 (2005) (162)
- Gene Microarrays Reveal Extensive Differential Gene Expression in Both CD4+ and CD8+ Type 1 and Type 2 T Cells1 (2001) (158)
- Tumor-Specific Tc1, But Not Tc2, Cells Deliver Protective Antitumor Immunity1 (2001) (153)
- Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. (2006) (149)
- Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo (1994) (146)
- Dissecting cellular crosstalk by sequencing physically interacting cells (2020) (133)
- CD80 Costimulation Is Essential for the Induction of Airway Eosinophilia (1997) (130)
- Differential Requirement for CD80 and CD80/CD86-Dependent Costimulation in the Lung Immune Response to an Influenza Virus Infection1 (2000) (115)
- Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses (2020) (109)
- Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. (1996) (103)
- Tumor Immunotherapy by Epicutaneous Immunization Requires Langerhans Cells1 (2008) (100)
- Functionally distinct subsites on a class II major histocompatibility complex molecule (1987) (93)
- Langerin+CD8α+ Dendritic Cells Are Critical for Cross-Priming and IL-12 Production in Response to Systemic Antigens1 (2009) (86)
- Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells (2008) (86)
- Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors. (1998) (82)
- Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Can Regulate Dendritic Cell–induced Activation and Cytotoxicity of CD8+ T Cells Independently of CD4+T Cell Help (1999) (78)
- Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer. (1987) (72)
- Blockade of CD28/B7 co‐stimulation by mCTLA4‐Hγ1 inhibits antigen‐induced lung eosinophilia but not Th2 cell development or recruitment in the lung (1997) (67)
- Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours? (2008) (66)
- Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. (2000) (65)
- Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles (2017) (64)
- Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation. (1999) (62)
- A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy. (2014) (61)
- Monocyte-Derived Dendritic Cells Are Essential for CD8+ T Cell Activation and Antitumor Responses After Local Immunotherapy (2015) (58)
- Type I interferon is required for T helper (Th) 2 induction by dendritic cells (2017) (58)
- Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge (1997) (58)
- Interferon‐γ‐ and interleukin‐4‐producing T cells can be primed on dendritic cells in vivo and do not require the presence of B cells (1994) (56)
- CTLA4‐Ig inhibits optimal T helper 2 cell development but not protective immunity or memory response to Nippostrongylus brasiliensis (1999) (55)
- Helminth-Conditioned Dendritic Cells Prime CD4+ T Cells to IL-4 Production In Vivo (2014) (52)
- The molecular basis of class II MHC allelic control of T cell responses. (1991) (51)
- Diminished antigen processing by endosomal acidification mutant antigen-presenting cells. (1989) (49)
- The Differentiation of CD4+ T-Helper Cell Subsets in the Context of Helminth Parasite Infection (2014) (47)
- B‐Lymphocytes Activated by CD40 Ligand Induce an Antigen‐Specific Anti‐Tumour Immune Response by Direct and Indirect Activation of CD8+ T‐cells (2004) (47)
- Effector lymphoid tissue and its crucial role in protective immunity. (2005) (47)
- Thymic stromal lymphopoietin drives the development of IL-13+ Th2 cells (2018) (46)
- Targeting Antigen to MHC Class II Molecules Promotes Efficient Cross-Presentation and Enhances Immunotherapy1 (2009) (46)
- I-A-restricted T cell antigen recognition. Analysis of the roles of A alpha and A beta using DNA-mediated gene transfer (1986) (45)
- Murine Melanoma-Infiltrating Dendritic Cells Are Defective in Antigen Presenting Function Regardless of the Presence of CD4+CD25+ Regulatory T Cells (2011) (43)
- Killing of Dendritic Cells: A Life Cut Short or a Purposeful Death? (2001) (43)
- Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response. (2008) (43)
- Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors (2007) (43)
- CD326loCD103loCD11blo Dermal Dendritic Cells Are Activated by Thymic Stromal Lymphopoietin during Contact Sensitization in Mice (2014) (42)
- Resting B Cells Suppress Tumor Immunity via an MHC Class-II Dependent Mechanism (2007) (41)
- Killing of Dendritic Cells (2001) (41)
- Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarization (2021) (41)
- Potent anti‐tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand (2010) (38)
- Increased Numbers of Monocyte-Derived Dendritic Cells during Successful Tumor Immunotherapy with Immune-Activating Agents (2013) (37)
- The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity (2005) (35)
- DestVI identifies continuums of cell types in spatial transcriptomics data (2022) (34)
- Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy (2013) (33)
- Single-Cell Analysis of Diverse Pathogen Responses Defines a Molecular Roadmap for Generating Antigen-Specific Immunity. (2019) (31)
- Allergen-Specific CTL Require Perforin Expression To Suppress Allergic Airway Inflammation (2012) (27)
- Dendritic Cells Treated with Lipopolysaccharide Up-Regulate Serine Protease Inhibitor 6 and Remain Sensitive to Killing by Cytotoxic T Lymphocytes In Vivo1 (2008) (27)
- CD80 Costimulation Is Required for Th2 Cell Cytokine Production But Not for Antigen-Specific Accumulation and Migration into the Lung1 (2001) (23)
- Combined TLR Stimulation With Pam3Cys and Poly I: C Enhances Flt3-Ligand Dendritic Cell Activation for Tumor Immunotherapy (2012) (22)
- Investigation of chimeric reads using the MinION (2017) (22)
- T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. (1982) (22)
- Effector CD8+ T cells activated in vitro confer immediate and long‐term tumor protection in vivo (2008) (20)
- Dendritic cells in Th2 immune responses and allergic sensitization (2020) (20)
- Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge (2021) (20)
- The contribution of mutant amino acids to alloantigenicity (1989) (18)
- Sister chromatid exchanges induced in vivo and in vitro by chemical carcinogens in mouse lymphocytes carrying endogenized Moloney leukemia virus. (1983) (18)
- High-dimensional analysis of intestinal immune cells during helminth infection (2020) (18)
- Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells. (2000) (17)
- IL-4 Is a Key Requirement for IL-4- and IL-4/IL-13-Expressing CD4 Th2 Subsets in Lung and Skin (2018) (16)
- The effects of B7‐dependent costimulation on T cell division and survival in vivo and in vitro are dependent on antigen concentration (2003) (16)
- Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge (2021) (16)
- Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis (2012) (16)
- Increasing the Survival of Dendritic Cells In Vivo Does Not Replace the Requirement for CD4+ T Cell Help during Primary CD8+ T Cell Responses1 (2007) (15)
- Conditions for the generation of cytotoxic CD4+ Th cells that enhance CD8+ CTL-mediated tumor regression (2016) (15)
- Long-term deposition of inhaled antigen in lung resident CD11b-CD11c+ cells. (2007) (15)
- Dendritic cells and the skin environment. (2020) (15)
- The role of B 7 costimulation in T-cell immunity (15)
- Long-Term Deposition of Inhaled Antigen in Lung Resident CD11b−CD11c+ Cells (2007) (15)
- Toll-Like Receptor 4, but Not Neutrophil Extracellular Traps, Promote IFN Type I Expression to Enhance Th2 Responses to Nippostrongylus brasiliensis (2017) (14)
- Murine CD4+ T Cell Responses Are Inhibited by Cytotoxic T Cell-Mediated Killing of Dendritic Cells and Are Restored by Antigen Transfer (2012) (14)
- Clec9A+ Dendritic Cells Are Not Essential for Antitumor CD8+ T Cell Responses Induced by Poly I:C Immunotherapy (2018) (13)
- Investigation of chimeric reads using the MinION. (2017) (12)
- Fate mapping analysis reveals a novel murine dermal migratory Langerhans-like cell population (2021) (11)
- Paclitaxel inhibits killing by murine cytotoxic T lymphocytes in vivo but not in vitro (2010) (11)
- Administration of α‐galactosylceramide impairs the survival of dendritic cell subpopulations in vivo (2011) (10)
- Antigen-specific cytotoxic T lymphocytes target airway CD103+ and CD11b+ dendritic cells to suppress allergic inflammation (2015) (10)
- 5,6‐Dimethylxanthenone‐4‐acetic acid treatment of a non‐immunogenic tumour does not synergize with active or passive CD8+ T‐cell immunotherapy (2006) (10)
- Dermal IRF4+ dendritic cells and monocytes license CD4+ T helper cells to distinct cytokine profiles (2020) (10)
- IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo. (2004) (9)
- Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies (2006) (8)
- Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV). (1984) (8)
- Monosodium Urate Crystals Induce Upregulation of NK1.1-Dependent Killing by Macrophages and Support Tumor-Resident NK1.1+ Monocyte/Macrophage Populations in Antitumor Therapy (2015) (8)
- The molecular basis of antigen presentation. (1988) (8)
- Activation-Induced TIM-4 Expression Identifies Differential Responsiveness of Intestinal CD103+ CD11b+ Dendritic Cells to a Mucosal Adjuvant (2016) (8)
- Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus. (1984) (7)
- CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion (2007) (7)
- Inefficient boosting of antitumor CD8+ T cells by dendritic-cell vaccines is rescued by restricting T-cell cytotoxic functions (2012) (7)
- Simultaneous Polychromatic Immunofluorescent Staining of Tissue Sections and Consecutive Imaging of up to Seven Parameters by Standard Confocal Microscopy (2019) (7)
- Hyperuricaemic UrahPlt2/Plt2 mice show altered T cell proliferation and defective tumor immunity after local immunotherapy with Poly I:C (2018) (7)
- The emerging role of the dendritic cell in novel cancer therapies. (1998) (7)
- IL-1βR-dependent priming of antitumor CD4+ T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria (2015) (6)
- Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols (2019) (6)
- The control of CD8+ T cell responses is preserved in perforin‐deficient mice and released by depletion of CD4+CD25+ regulatory T cells (2013) (6)
- Tumour antigens on tap (2002) (6)
- Sister chromatid exchanges and chromosomal aberrations induced by mitomycin C in mouse lymphocytes carrying a leukemogenic virus. (1983) (5)
- Different Susceptibility of BALB/Mo and BALB/c Mice to Cytogenetic Damage Induced by Urethan (1983) (5)
- The MBP-reactive repertoire is shaped by recognition of minor histocompatibility antigens (2004) (5)
- Induction of DNA repair synthesis by ultraviolet radiation and methylmethanesulphonate in cultured mouse lymphocytes. (1983) (5)
- Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones. (1985) (4)
- T-Lymphocyte Tolerance in RNA Tumor Virus Oncogenesis: A Model for the Clonal Abortion Hypothesis (1983) (4)
- Tissue localization and frequency of antigen‐specific effector CD4+ T cells determines the development of allergic airway inflammation (2005) (4)
- Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells (2008) (4)
- Role of Infectious Virus Expression and Immune Response in Retrovirus-Induced Oncogenesis (1984) (3)
- Deliver Protective Antitumor Immunity Tumor-Specific Tc1, But Not Tc2, Cells (2001) (3)
- Comment on: Repositioning TH cell polarization from single cytokines to complex help (2022) (3)
- Ine Y cient presentation of tumor-derived antigen by tumor-in W ltrating dendritic cells (2008) (2)
- Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice. (1984) (2)
- A semi-automated technique for adenoma quantification in the ApcMin mouse using FeatureCounter (2019) (2)
- Single-cell analysis of intestinal immune cells during helminth infection (2019) (2)
- Lymphokine-induced cytotoxic cell generation in thymus and spleen cell cultures. (1987) (2)
- IL‐13 in dermal type‐2 dendritic cell specialization: From function to therapeutic targeting (2022) (1)
- BCL6 deletion in CD4 T cells does not affect Th2 effector mediated immunity in the skin (2022) (1)
- Short- and Long-term Studies on Chemical Carcinogenesis in BALB/Mo Mice (1984) (1)
- The skin environment controls local dendritic cell differentiation and function through innate IL-13 (2021) (1)
- Cordycepin reduces the sensitivity of BALB/Mo mouse lymphocytes to the induction of sister chromatid exchanges. (1985) (1)
- 9 – Ia Structure and Immune Recognition (1988) (0)
- InflammationExpression To Suppress Allergic Airway Allergen-Specific CTL Require Perforin (2012) (0)
- Efficient depletion of chronic lymphocytic leukemia B cells using serial rounds of immunomagnetic depletion. (2013) (0)
- AgentsImmunotherapy with Immune-Activating Dendritic Cells during Successful Tumor Increased Numbers of Monocyte-Derived (2013) (0)
- A central role for Type I IFN in Th2 response induction by dendritic cells (2017) (0)
- Monocyte-derived dendritic cells (2013) (0)
- Markers of effective anti-tumor CTL populations for adoptive cell therapy (165.5) (2012) (0)
- Monocyte-derived dendritic cells are critical for the induction of anti-tumor immune responses (TUM4P.932) (2014) (0)
- 316 A unique population of dermal conventional dendritic cells enhances TH2 and inhibits TH17 cell polarization in healthy skin (2022) (0)
- T Cells to IL-4 Production In Vivo + CD4Helminth-Conditioned Dendritic Cells Prime (2014) (0)
- Infection Response to an Influenza Virus Costimulation in the Lung Immune and CD 80 / CD 86-Dependent Differential Requirement for CD 80 (1999) (0)
- Arginase-2 dampens fetal immunity Fetal dendritic cells give mum a break (2017) (0)
- Author response: High-dimensional analysis of intestinal immune cells during helminth infection (2019) (0)
- Author Correction: Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarization (2022) (0)
- Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus. (1983) (0)
- 1005 Low levels of IL-13 are constitutively produced in healthy skin and locally imprint a pro-type 2 immune response (2023) (0)
- A guideline for the appropriate recognition of shared resource laboratories in publication (2022) (0)
- CTL differentiation and function (WS-108) Chairpersons: Hideo Yagita, Laurence Boumsell (2010) (0)
- Author Correction: Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarization (2022) (0)
- in Antitumor Therapy Monocyte/Macrophage Populations + NK1.1Macrophages and Support Tumor-Resident Upregulation of NK1.1-Dependent Killing by Monosodium Urate Crystals Induce (2015) (0)
- Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols (2019) (0)
- Immunization Requires Langerhans Cells Tumor Immunotherapy by Epicutaneous (2008) (0)
- Dendritic cells in Th2 immune responses (P1313) (2013) (0)
- Migration into the Lung Antigen-Specific Accumulation and Cytokine Production But Not for CD80 Costimulation Is Required for Th2 Cell (2001) (0)
- Helminth-conditioned dendritic cells prime CD4+ T cells to IL4 production in vivo (IRC5P.469) (2014) (0)
- and Migration into the Lung for Antigen-Specific Accumulation Not Th2 Cell Cytokine Production But CD80 Costimulation Is Required for (2010) (0)
- Fate mapping analysis reveals a novel dermal migratory Langerhans-like cell population (2020) (0)
- Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses (2020) (0)
- Fetal dendritic cells give mum a break (2017) (0)
- Type 1 and Type 2 T Cells + and CD 8 + Differential Gene Expression in Both CD 4 Gene Microarrays Reveal Extensive (2001) (0)
- Dissecting cellular crosstalk by sequencing physically interacting cells (2020) (0)
- Author response: Fate mapping analysis reveals a novel murine dermal migratory Langerhans-like cell population (2021) (0)
This paper list is powered by the following services:
Other Resources About Franca Ronchese
What Schools Are Affiliated With Franca Ronchese?
Franca Ronchese is affiliated with the following schools:
